Study guide
5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention
Key Takeaways Explain This Topic AI
Uncomplicated lower urinary tract infections (acute cystitis) in non-pregnant women are managed empirically with a 3-day course of oral nitrofurantoin (avoid if eGFR <45 mL/min or at term) or trimethoprim (avoid in 1st trimester pregnancy), whereas men require a 7-day course.
Acute pyelonephritis presents with fever, flank pain, and systemic toxicity; it requires blood and urine cultures, prompt antibiotics per NICE NG111 (cefalexin or co-amoxiclav for 7–10 days, ciprofloxacin for 7 days, or trimethoprim for 14 days if susceptible), and hospital admission if septic or unable to tolerate oral intake.
Nephrolithiasis presents with severe colicky loin-to-groin pain and microscopic haematuria; non-contrast low-dose CT KUB is the gold standard diagnostic imaging, and rectal or IV NSAIDs provide superior first-line analgesia compared to opioids.
An obstructing ureteric calculus accompanied by active infection (infected hydronephrosis / septic stone) is a time-critical urological emergency demanding urgent percutaneous nephrostomy decompression or retrograde JJ stenting alongside IV antibiotics to prevent fatal urosepsis.
Last updated: October 2026
Urology: Urinary Tract Infections, Renal Colic & Urinary Retention
Urological pathology spans a broad spectrum of acute clinical encounters in the United Kingdom, from community-acquired uncomplicated cystitis to time-critical emergencies such as septic obstructed nephropathy and acute urinary retention. Rapid differentiation of uncomplicated conditions from obstructive or systemic emergencies is vital to prevent permanent parenchymal loss and fatal sepsis.
1. Urinary Tract Infections: Lower UTI vs. Acute Pyelonephritis
Urinary tract infections (UTIs) are primarily caused by ascending colonic gram-negative uropathogens. Escherichia coli accounts for 75–80% of all community-acquired infections. Other causative organisms include Staphylococcus saprophyticus (frequently isolated in young, sexually active females), Klebsiella pneumoniae , Enterococcus faecalis , and Proteus mirabilis (a urease-producing organism that hydrolyses urea to ammonia, producing an alkaline urine pH > 7.0 that precipitates magnesium ammonium phosphate struvite staghorn calculi ).
Clinical Presentation & Diagnostic Differentiation
Lower UTI (Acute Cystitis): Localised inflammation of the bladder mucosa. Clinical features include dysuria, urinary frequency, urgency, suprapubic pain or tenderness, and microscopic/macroscopic haematuria. Systemic symptoms (fever, chills, rigors, flank pain) are characteristically absent .
Acute Pyelonephritis (Upper UTI): Infection of the renal pelvis and parenchyma. Characterised by acute systemic toxicity with high fever ( > 38°C ), shaking rigors, nausea, vomiting, severe unilateral loin/flank pain, and marked costovertebral angle tenderness (renal angle tenderness) .
NICE Antimicrobial Prescribing Protocols
Clinical Entity Patient Population First-Line Antimicrobial Regimen Duration Critical PLAB 1 Prescribing Rules
Uncomplicated Lower UTI Non-pregnant adult females Nitrofurantoin 100 mg MR BD, OR Trimethoprim 200 mg BD 3 days Nitrofurantoin is ineffective and contraindicated if eGFR < 45 mL/min (inadequate urinary concentration) and at term (risk of neonatal haemolysis). Trimethoprim is a teratogenic folate antagonist contraindicated in the 1st trimester of pregnancy .
Lower UTI in Men Adult males Nitrofurantoin 100 mg MR BD, OR Trimethoprim 200 mg BD 7 days Always considered complicated; investigate for bladder outflow obstruction, urethral stricture, or chronic prostatitis.
UTI in Pregnancy Pregnant females (symptomatic or asymptomatic bacteriuria) Nitrofurantoin (avoid at term) OR Cefalexin 500 mg BD 7 days Urine culture for asymptomatic bacteriuria is offered at the booking visit. Asymptomatic bacteriuria must always be treated to prevent acute pyelonephritis and premature labour.
Catheter-Associated UTI (CAUTI) Indwelling urethral/suprapubic catheter No upper UTI symptoms: Nitrofurantoin (if eGFR ≥45), Trimethoprim or Amoxicillin (if susceptible); upper UTI symptoms: Cefalexin , Co-amoxiclav (if susceptible) or Ciprofloxacin (NICE NG113) 7 days (7–10 days with upper symptoms) Do NOT treat asymptomatic bacteriuria in catheterised patients! If a catheter has been in place for more than 7 days, remove or change it as soon as possible, without delaying antibiotics, and send a urine sample from the new catheter.
Acute Pyelonephritis (Mild / Outpatient) Haemodynamically stable, oral intake tolerated Cefalexin 500 mg BD–TDS, OR Co-amoxiclav 500/125 mg TDS (if susceptible), OR Ciprofloxacin 500 mg BD, OR Trimethoprim 200 mg BD (if susceptible) Cefalexin/co-amoxiclav 7–10 days; ciprofloxacin 7 days; trimethoprim 14 days (NICE NG111) Always send urine and blood cultures prior to treatment. Ciprofloxacin is effective but reserved due to tendonitis and C. difficile risks.
Acute Pyelonephritis (Severe / Inpatient) Septic, vomits oral meds, pregnant, frail IV Ceftriaxone 1–2 g OD, OR IV Co-amoxiclav 1.2 g TDS, OR IV Gentamicin 5–7 mg/kg OD (per local policy) Review IV antibiotics by 48 hours; total course usually 7–10 days Urgent inpatient admission, IV fluid resuscitation, step-down to oral targeted therapy guided by culture and clinical response.
2. Nephrolithiasis & Ureteric Calculi (Renal Colic)
Nephrolithiasis develops when urinary solutes exceed solubility saturation, resulting in crystal nucleation, aggregation, and stone formation. Types of calculi include:
Calcium Oxalate (70–80%): Radio-opaque; promoted by hypercalciuria, hyperoxaluria, and hypocitraturia.
Calcium Phosphate (10%): Radio-opaque; associated with primary hyperparathyroidism and distal Renal Tubular Acidosis (Type 1, high urinary pH).
Uric Acid (5–10%): Radiolucent on plain X-rays (visible on CT); promoted by persistently acidic urine (pH < 5.5) and hyperuricaemia (gout, myeloproliferative disorders).
Struvite (Triple Phosphate / Magnesium Ammonium Phosphate) (5–10%): Moderately radio-opaque; form large staghorn calculi filling the renal pelvicalyceal system secondary to urease-producing bacterial infections ( Proteus , Klebsiella ).
Cystine (1%): Faintly radio-opaque; caused by autosomal recessive cystinuria.
Clinical Presentation
Classical renal colic is characterized by the sudden onset of excruciating, sharp, spasmodic loin-to-groin pain radiating across the ipsilateral flank toward the iliac fossa, scrotum, or labia majora. Patients are visibly restless, pacing or writhing on the bed unable to find a comfortable posture (contrasting with peritonitis, where patients lie rigidly motionless). Non-visible (microscopic) haematuria is present on dipstick in >90% of cases.
Diagnostic Imaging & Acute Analgesia
Gold Standard Imaging: Non-contrast low-dose CT KUB (Kidney, Ureter, Bladder) performed within 24 hours of presentation (NICE NG118). Low-dose CT has >99% sensitivity and specificity, detecting calculi of all compositions (including radiolucent uric acid stones) and precisely measuring stone diameter and skin-to-stone distance.
Pregnancy & Paediatrics: Renal tract ultrasound is first-line imaging to avoid ionising radiation.
First-Line Analgesia: Intravenous or rectal Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) , such as rectal diclofenac (100 mg) or IV ketorolac (15–30 mg) . NSAIDs directly inhibit renal prostaglandin synthesis, reducing renal blood flow and glomerular filtration, thereby decompressing the renal capsule and halting ureteric smooth muscle spasm. Clinical trials confirm NSAIDs provide faster, more effective pain relief with fewer side effects than opioids. Intravenous paracetamol or opioids (morphine with antiemetic) are reserved for patients with strict NSAID contraindications (severe renal impairment, active peptic ulceration, third-trimester pregnancy, NSAID-exacerbated respiratory disease).
- Definitive Stone Management by Size [ Ureteric Calculus Identified on CT KUB ]
- │
- ┌──────────────────────────┴──────────────────────────┐
- ▼ ▼
- [ Calculus < 5 mm Diameter ] [ Calculus >= 5 mm Diameter ]
- Spontaneous passage in >80-90% • Lower spontaneous passage rate
- Outpatient conservative management • Assess for intervention
- Oral analgesia & hydration │
- Medical Expulsive Therapy (MET): ┌────────┴────────┐
- Tamsulosin 400 mcg OD ▼ ▼
- │ [ 5 - 10 mm ] [ > 10 mm or Staghorn ]
┌────────────┴────────────┐ Trial of MET or Active Surgical Clearance:
- ▼ ▼ Early ESWL / URS • URS + Holmium Laser
- [ Stone Passes ] [ Persistent Pain / ] • PCNL (>20 mm staghorn)
- Follow-up complete [ Failure to pass at 4w ]
- Escalate to ESWL / URS
Medical Expulsive Therapy (MET): Oral tamsulosin 400 mcg daily (an alpha-1 adrenoceptor antagonist) relaxes smooth muscle in the distal ureter, accelerating stone expulsion and reducing recurrent analgesic requirements for stones < 10 mm.
Extracorporeal Shock Wave Lithotripsy (ESWL): Acoustic shock waves focus under fluoroscopy to fragment stones into passable gravel. Ideal for renal or upper ureteric calculi < 20 mm. Contraindicated in pregnancy, untreated UTI, and bleeding diathesis.
Ureteroscopy (URS) with Laser Lithotripsy: Endoscopic visual clearance with holmium laser fragmentation and basket extraction; first-line for lower/mid ureteric stones and stones > 10 mm.
Percutaneous Nephrolithotomy (PCNL): Direct percutaneous nephrostomy tract creation into the renal pelvis. Gold standard for large staghorn calculi (> 20 mm) or complex lower pole renal stones.
Caution
The Lethal Urological Emergency: Septic Obstructed Kidney (Infected Hydronephrosis) An obstructing ureteric calculus in the presence of proximal bacterial infection produces pyonephrosis and rapid development of life-threatening uroseptic shock. Hallmarks include: fever (>38°C), rigors, tachycardia, hypotension, severe loin pain, and hydronephrosis on CT/ultrasound . Antibiotics cannot penetrate an obstructed pyelocaliceal system! Emergency management requires immediate resuscitation, IV broad-spectrum antibiotics, and urgent surgical decompression of the collecting system within hours via either:
Urgent Percutaneous Nephrostomy (PCN) tube insertion under radiological guidance, OR
Retrograde Ureteric JJ Stent insertion past the obstruction under cystoscopic guidance.
3. Acute Urinary Retention: Assessment & Catheterisation Protocols
Acute Urinary Retention (AUR) is the sudden, painful inability to void urine, accompanied by marked suprapubic distress and an exquisitely tender, palpable bladder that is dull to percussion.
Clinical Classification & Common Aetiologies
Prostatic Enlargement: Benign Prostatic Hyperplasia (BPH) is the underlying cause in >70% of male cases; prostate adenocarcinoma.
Pharmacological Causes: Very common in hospitalised elderly patients. Anticholinergic / antimuscarinic agents (oxybutynin, tolterodine), tricyclic antidepressants (amitriptyline), opioids (morphine, oxycodone), first-generation antihistamines (chlorphenamine), and nasal decongestants (pseudoephedrine).
Urethral Pathology: Urethral strictures, bladder neck contractures, urethral foreign body, clot retention (gross haematuria with obstructive luminal clots).
Neurological: Cauda equina syndrome (always check perineal sensation, digital rectal examination for anal tone, and lower limb neurology), acute spinal trauma, multiple sclerosis, diabetic cystopathy.
Other Triggers: Severe constipation / faecal impaction, post-operative anaesthesia, acute prostatitis, genital herpes.
Immediate Emergency Management Protocol
Immediate Urethral Catheterisation: Perform urgent bladder decompression using a 12–14 Fr Foley catheter under sterile conditions with generous instillation of lubricating local anaesthetic gel. Document the immediate residual urine volume (typically 500–1500 mL). Completely drain the bladder immediately; historical practice of clamping the catheter to prevent ex vacuo haematuria is obsolete and unsafe.
Failed Catheterisation: If resistance is encountered (e.g. stricture or false passage), do not use force. Contact urology immediately for flexible cystoscopy or urgent suprapubic catheter insertion.
Initiate Alpha-Blocker Therapy: Prescribe tamsulosin 400 mcg once daily immediately. Tamsulosin relaxes prostatic smooth muscle and doubles the likelihood of a successful Trial Without Catheter (TWOC) .
Trial Without Catheter (TWOC): Attempt catheter removal after at least 48 to 72 hours of alpha-blocker therapy.
Monitor for Post-Obstructive Diuresis: Occurs after relieving chronic retention. Defined as urine output > 200 mL/hour for ≥ 2 consecutive hours . Monitor fluid balance, electrolytes, and replace 50% of hourly urine volume with IV 0.45% or 0.9% normal saline to prevent vascular collapse while allowing physiological excretion of retained solutes.